Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001988762 | SCV002285340 | uncertain significance | Saldino-Mainzer syndrome | 2021-11-13 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with IFT140-related conditions. This variant is present in population databases (rs771632573, gnomAD 0.01%). This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 1460 of the IFT140 protein (p.Asp1460Gly). |
Fulgent Genetics, |
RCV002492277 | SCV002778757 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2021-10-18 | criteria provided, single submitter | clinical testing |